Alteplase

In the US, Alteplase (alteplase systemic) is a member of the drug class thrombolytics and is used to treat Heart Attack, Ischemic Stroke, IV Catheter Clot and Pulmonary Embolism.

US matches:

• Alteplase


• Alteplase, recombinant Intravenous


• Alteplase, Recombinant

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AD02,S01XA13

CAS registry number (Chemical Abstracts Service)

0105857-23-6

Chemical Formula

C2569-H3894-N746-O781-S40

Molecular Weight

59011

Therapeutic Category

Anticoagulant agent: Fibrinolytic enzyme

Chemical Name

Plasminogen activator (human tissue-type protein moiety), glycoform α

Foreign Names

• Alteplasum (Latin)
• Alteplase (German)
• Alteplase (French)
• Alteplasa (Spanish)

Generic Names

• Alteplase (OS: USAN, BAN)
• rt-PA (IS: USAN)
• t-PA (IS)
• Alteplase (PH: USP 32)
• Alteplase for Injection (PH: USP 32, Ph. Eur. 6, BP 2010)
• Altéplase pour solution injectable (PH: Ph. Eur. 6)
• Alteplase zur Injektion (PH: Ph. Eur. 6)
• Alteplasum ad iniectabile (PH: Ph. Eur. 6)

Brand Names

• Actilyse
  Boehringer Ingelheim, Argentina; Boehringer Ingelheim, Austria; Boehringer Ingelheim, Australia; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Bulgaria; Boehringer Ingelheim, Brazil; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Chile; Boehringer Ingelheim, China; Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Czech Republic; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Algeria; Boehringer Ingelheim, Estonia; Boehringer Ingelheim, Spain; Boehringer Ingelheim, Finland; Boehringer Ingelheim, France; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Georgia; Boehringer Ingelheim, Greece; Boehringer Ingelheim, Hong Kong; Boehringer Ingelheim, Croatia (Hrvatska); Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Indonesia; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Israel; Boehringer Ingelheim, Iceland; Boehringer Ingelheim, Italy; Boehringer Ingelheim, Lithuania; Boehringer Ingelheim, Luxembourg; Boehringer Ingelheim, Latvia; Boehringer Ingelheim, Malta; Boehringer Ingelheim, Mexico; Boehringer Ingelheim, Malaysia; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Norway; Boehringer Ingelheim, New Zealand; Boehringer Ingelheim, Oman; Boehringer Ingelheim, Peru; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Portugal; Boehringer Ingelheim, Romania; Boehringer Ingelheim, Serbia; Boehringer Ingelheim, Russian Federation; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, Singapore; Boehringer Ingelheim, Slovenia; Boehringer Ingelheim, Slovakia; Boehringer Ingelheim, Thailand; Boehringer Ingelheim, Tunisia; Boehringer Ingelheim, Turkey; Boehringer Ingelheim, Taiwan; Boehringer Ingelheim, Venezuela; Boehringer Ingelheim, South Africa; German Remedies, India



• Actilyse Cathflo
  Boehringer Ingelheim, Germany



• Activacin
  Kyowa Hakko Kirin, Japan



• Activase
  Genentech, United States; Roche, Canada



• Cathflo
  Genentech, United States; Roche, Canada



• Grtpa
  Tanabe Mitsubishi, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.